Page 31 - Note Regarding News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TSX-V: OCO) (“ Oroco” or “ Rodriguez”) of Mexico City to acquire 25 shares of Xochipala Gold, S.A. de C.V. (“ Xochipala Gold”) for US$1.5 million.  Xochipala Gold holds 100% of the registered title (85% of the beneficial ownership) to the seven core concessions (the “ Core Concessions”) of the Company’s Santo Tomas Project.  The shares of Xochipala Gold being acquired currently represent 8.5% of the beneficial ownership of the Core Concessions. Background:  Prior to reaching the current agreements with Rodriguez, the Company’s held all 180 issued shares of Xochipala Gol...

PsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement of its Neuropsychiatric Drug Discovery Platform, Expediting its IND Submission to the FDA News provided by Share this article Share this article PsyBio" or the " Company"), a biotechnology company pioneering the next generation of targeted psychoactive medications, announces today that it has amended its master sponsored agreement with Miami University based in Oxford, Ohio (the " Amended Agreement") to extend and expand the research efforts of the laboratory of Dr. J. Andrew Jones in the Department of Che...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. RespireRx Pharmaceuticals Inc. Provides Update on Its Development Programs RespireRX Pharmaceuticals Inc.April 22, 2021 GMT Glen Rock, N.J., April 22, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to provide an update on its therapeutic drug development programs. EndeavourRx Scie...

PsyBio Therapeutics Appoints Pharmaceutical Veteran Bob Oliver to its Board of Directors Mr. Oliver joins PsyBio bringing over 25 years of executive pharmaceutical experience having held various senior positions at Otsuka, Wyeth and Johnson & Johnson News provided by Share this article Share this article PsyBio" or the " Company"), a biotechnology company pioneering the next generation of targeted psychoactive medications, is pleased to announce the appointment of Mr. Bob Oliver to the Company's board of directors (the " Board"), effective immediately. The Company is developing a platform tec...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Medigus: Polyrizon Commenced a Pre-Clinical Study Testing Several Formulations of its Bio-Gel ... Medigus LtdApril 12, 2021 GMT OMER, Israel, April 12, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced that Polyrizon Ltd. (which Medigus owns 33.24% of its share capital), a private company engaged in developing highly differentiated biological gels for the purpose of protecting patient...